HAEMONETICS CORP

HAE NYSE CIK: 0000313143

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation MA
Business Address 125 SUMMER STREET, BOSTON, MA, 02110
Mailing Address 125 SUMMER STREET, BOSTON, MA, 02110
Phone 7818487100
Fiscal Year End 0328
EIN 042882273

Financial Overview

FY2025

$2.45B
Total Assets

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G Passive beneficial ownership (>5%) February 13, 2026 View on SEC
8-K Current report of material events February 12, 2026 View on SEC
10-Q Quarterly financial report February 5, 2026 View on SEC
8-K Current report of material events February 5, 2026 View on SEC
8-K Current report of material events January 9, 2026 View on SEC
4 Insider stock transaction report November 12, 2025 View on SEC
8-K Current report of material events November 6, 2025 View on SEC
10-Q Quarterly financial report November 6, 2025 View on SEC
4 Insider stock transaction report November 3, 2025 View on SEC
4 Insider stock transaction report September 24, 2025 View on SEC

Material Events

8-K Acquisition January 9, 2026
High Impact
  • HAEMONETICS CORP acquired Vivasure Medical Limited, a company specializing in cutting-edge percutaneous vessel closure technology.
  • The acquisition expands HAEMONETICS' business, adding advanced technology to its product lineup and strengthening its position in the medical device market.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.